SOTALOL HYDROCHLORIDE TABLETS AF

SOTALOL HYDROCHLORIDE TABLETS AF was reported 2536 times

SOTALOL HYDROCHLORIDE TABLETS AF is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VESSEL PUNCTURE SITE DISCOLOURATION 2 0.3333
1 FOETAL TACHYARRHYTHMIA 2 0.1333
2 MEDICAL OBSERVATION 9 0.0841
3 LIVER FUNCTION TEST NORMAL 2 0.0800
4 CARDIOACTIVE DRUG LEVEL DECREASED 8 0.0468
5 CLINICAL DEATH 2 0.0385
6 TOOTH AVULSION 3 0.0170
7 GASTROINTESTINAL ANGIECTASIA 2 0.0169
8 EOSINOPENIA 2 0.0152
9 ERYTHROMELALGIA 4 0.0109
10 GRANDIOSITY 4 0.0109
11 CRYPTOGENIC ORGANISING PNEUMONIA 2 0.0108
12 VARICOSE VEIN OPERATION 2 0.0100
13 VENTRICULAR DYSKINESIA 2 0.0096
14 STENOTROPHOMONAS INFECTION 13 0.0096
15 ANGIOSARCOMA 4 0.0087
16 CARCINOGENICITY 2 0.0083
17 TACHYCARDIA FOETAL 4 0.0080
18 PRESSURE OF SPEECH 5 0.0077
19 TORSADE DE POINTES 56 0.0071
20 CEREBELLAR HAEMATOMA 2 0.0071
21 LONG QT SYNDROME 16 0.0067
22 ENTEROBACTER BACTERAEMIA 2 0.0066
23 IMPAIRED FASTING GLUCOSE 2 0.0066
24 HYDROPS FOETALIS 4 0.0065
25 INCARCERATED HERNIA 2 0.0065
26 ELECTROMECHANICAL DISSOCIATION 5 0.0063
27 RIGHT ATRIAL DILATATION 3 0.0059
28 ABDOMINAL HAEMATOMA 1 0.0058
29 MUSCLE HYPERTROPHY 2 0.0057
30 BRASH SYNDROME 8 0.0057
31 VENOUS PRESSURE JUGULAR INCREASED 2 0.0055
32 MEDIASTINAL DISORDER 2 0.0053
33 ANISOCORIA 2 0.0053
34 SICK SINUS SYNDROME 6 0.0052
35 ELECTROCARDIOGRAM QT CORRECTED INTERVAL PROLONGED 4 0.0051
36 VAGINAL ULCERATION 2 0.0048
37 C-REACTIVE PROTEIN DECREASED 3 0.0046
38 VENTRICULAR ARRHYTHMIA 16 0.0044
39 VENTRICULAR TACHYCARDIA 72 0.0044
40 NEUROLOGICAL EXAMINATION ABNORMAL 2 0.0043
41 WOLFF-PARKINSON-WHITE SYNDROME 2 0.0042
42 CRANIAL NERVE PARALYSIS 2 0.0042
43 PLICATED TONGUE 2 0.0042
44 ELECTROCARDIOGRAM QT PROLONGED 149 0.0041
45 BRAIN STEM STROKE 2 0.0041
46 ACQUIRED HAEMOPHILIA 4 0.0040
47 LEFT VENTRICULAR DILATATION 2 0.0039
48 MYASTHENIC SYNDROME 3 0.0039
49 IGA NEPHROPATHY 6 0.0036
50 BRADYCARDIA FOETAL 3 0.0036
51 CARDIOVERSION 5 0.0036
52 CEREBRAL HAEMATOMA 12 0.0036
53 RIGHT VENTRICULAR DILATATION 2 0.0035
54 BLOOD OSMOLARITY DECREASED 2 0.0032
55 HENOCH-SCHONLEIN PURPURA 7 0.0032
56 LEFT ATRIAL DILATATION 4 0.0031
57 CONTRAINDICATED PRODUCT PRESCRIBED 5 0.0030
58 CLONUS 8 0.0029
59 PROSTATIC SPECIFIC ANTIGEN ABNORMAL 3 0.0029
60 LIVEDO RETICULARIS 6 0.0029
61 SYSTOLIC DYSFUNCTION 3 0.0028
62 DEVICE ELECTRICAL FINDING 2 0.0028
63 LABELLED DRUG-DRUG INTERACTION ISSUE 4 0.0028
64 ARRHYTHMIA SUPRAVENTRICULAR 3 0.0027
65 LABILE BLOOD PRESSURE 3 0.0025
66 ACOUSTIC NEUROMA 1 0.0024
67 TONGUE ERYTHEMA 2 0.0024
68 SEPTIC EMBOLUS 2 0.0024
69 HYPOMAGNESAEMIA 33 0.0024
70 LUNG HYPERINFLATION 2 0.0023
71 TONIC CLONIC MOVEMENTS 3 0.0023
72 ATRIOVENTRICULAR BLOCK FIRST DEGREE 10 0.0023
73 SINUS ARRHYTHMIA 3 0.0023
74 CARDIOACTIVE DRUG LEVEL INCREASED 3 0.0023
75 ANEURYSM RUPTURED 2 0.0022
76 BUNDLE BRANCH BLOCK RIGHT 10 0.0022
77 PROTHROMBIN LEVEL DECREASED 2 0.0021
78 BRADYCARDIA 111 0.0021
79 SUPRAVENTRICULAR EXTRASYSTOLES 7 0.0021
80 MUTISM 3 0.0021
81 DRUG ADMINISTERED IN WRONG DEVICE 2 0.0020
82 CARDIAC FIBRILLATION 3 0.0020
83 HAEMORRHAGIC TRANSFORMATION STROKE 3 0.0020
84 DAYDREAMING 3 0.0019
85 BREAST DISCOMFORT 2 0.0019
86 RIGHT VENTRICULAR DYSFUNCTION 2 0.0018
87 VENTRICULAR FIBRILLATION 20 0.0018
88 ATRIAL FIBRILLATION 174 0.0018
89 POST PROCEDURAL HAEMATOMA 3 0.0018
90 SINUS BRADYCARDIA 17 0.0018
91 ARTERIAL HAEMORRHAGE 2 0.0017
92 COMA SCALE ABNORMAL 5 0.0017
93 DILATATION ATRIAL 2 0.0017
94 BUNDLE BRANCH BLOCK LEFT 7 0.0016
95 EJECTION FRACTION ABNORMAL 2 0.0016
96 STAPHYLOCOCCAL SKIN INFECTION 2 0.0016
97 HELICOBACTER GASTRITIS 2 0.0016
98 INTERNATIONAL NORMALISED RATIO INCREASED 46 0.0016
99 VENTRICULAR HYPERTROPHY 4 0.0016
100 SUBCUTANEOUS HAEMATOMA 2 0.0016
101 CARDIAC VENTRICULAR THROMBOSIS 2 0.0015
102 PACKED RED BLOOD CELL TRANSFUSION 2 0.0015
103 ATRIAL FLUTTER 12 0.0015
104 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
105 INTERNATIONAL NORMALISED RATIO DECREASED 6 0.0015
106 PULSE ABSENT 7 0.0015
107 LEFT VENTRICULAR FAILURE 5 0.0015
108 ECHOCARDIOGRAM ABNORMAL 2 0.0014
109 BRONCHIAL OBSTRUCTION 2 0.0014
110 INTENSIVE CARE 2 0.0014
111 EXOPHTHALMOS 3 0.0014
112 AMYOTROPHIC LATERAL SCLEROSIS 3 0.0014
113 NOROVIRUS INFECTION 2 0.0014
114 PERIODONTITIS 3 0.0014
115 CARDIOMEGALY 17 0.0014
116 PERICARDIAL HAEMORRHAGE 3 0.0014
117 PULMONARY VALVE INCOMPETENCE 2 0.0014
118 NODAL RHYTHM 2 0.0014
119 HYPOVOLAEMIA 8 0.0014
120 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 14 0.0014
121 HYPOMANIA 5 0.0014
122 VENTRICULAR EXTRASYSTOLES 14 0.0013
123 LARGE INTESTINAL HAEMORRHAGE 3 0.0013
124 ADHESION 2 0.0013
125 CARDIOGENIC SHOCK 19 0.0013
126 ATRIOVENTRICULAR BLOCK SECOND DEGREE 4 0.0013
127 ISCHAEMIC CARDIOMYOPATHY 4 0.0013
128 INTRA-UTERINE DEATH 2 0.0012
129 CYSTITIS INTERSTITIAL 2 0.0012
130 STARING 3 0.0012
131 MITRAL VALVE INCOMPETENCE 14 0.0012
132 ACNE PUSTULAR 1 0.0012
133 BRADYARRHYTHMIA 2 0.0012
134 ABDOMINAL TENDERNESS 6 0.0012
135 SPLEEN DISORDER 2 0.0012
136 URINE OUTPUT DECREASED 10 0.0011
137 ARRHYTHMIA 54 0.0011
138 JAUNDICE CHOLESTATIC 4 0.0011
139 ANGIONEUROTIC OEDEMA 3 0.0011
140 CARDIAC ABLATION 2 0.0011
141 SINUS NODE DYSFUNCTION 2 0.0011
142 CARDIAC FLUTTER 7 0.0011
143 LOBAR PNEUMONIA 2 0.0011
144 BLOOD IRON INCREASED 2 0.0011
145 PEMPHIGOID 8 0.0011
146 DUODENAL ULCER HAEMORRHAGE 3 0.0010
147 ANURIA 9 0.0010
148 RHEUMATIC DISORDER 2 0.0010
149 DIZZINESS POSTURAL 10 0.0010
150 PSYCHIATRIC DECOMPENSATION 2 0.0010
151 BICYTOPENIA 2 0.0010
152 ORGANISING PNEUMONIA 5 0.0010
153 TRICUSPID VALVE INCOMPETENCE 8 0.0010
154 CARDIAC PACEMAKER INSERTION 6 0.0010
155 MUSCLE HAEMORRHAGE 4 0.0010
156 HYPERCAPNIA 3 0.0010
157 CORONARY ARTERY THROMBOSIS 2 0.0010
158 SUBDURAL HAEMATOMA 14 0.0010
159 DIASTOLIC DYSFUNCTION 3 0.0010
160 ATRIAL THROMBOSIS 2 0.0010
161 FOETAL DEATH 5 0.0010
162 EYELIDS PRURITUS 3 0.0010
163 INSULIN RESISTANCE 2 0.0010
164 ATRIAL TACHYCARDIA 2 0.0010
165 HEPATIC CYTOLYSIS 12 0.0009
166 AORTIC VALVE INCOMPETENCE 4 0.0009
167 REACTION TO DRUG EXCIPIENTS 2 0.0009
168 LISTLESS 3 0.0009
169 ARTERIOSCLEROSIS CORONARY ARTERY 6 0.0009
170 ATRIOVENTRICULAR BLOCK 7 0.0009
171 RETROPERITONEAL HAEMATOMA 2 0.0009
172 ELECTROCARDIOGRAM T WAVE INVERSION 2 0.0009
173 CYTOLYTIC HEPATITIS 3 0.0009
174 FAECES PALE 2 0.0009
175 PULMONARY ALVEOLAR HAEMORRHAGE 5 0.0009
176 COMPUTERISED TOMOGRAM ABNORMAL 2 0.0009
177 DRUG TOXICITY 12 0.0009
178 GENERALISED ERYTHEMA 5 0.0009
179 AUTOIMMUNE HAEMOLYTIC ANAEMIA 3 0.0009
180 EXTRASYSTOLES 6 0.0009
181 INGROWING NAIL 2 0.0008
182 DIVERTICULUM 6 0.0008
183 PRODUCT CONTAMINATION 3 0.0008
184 URINE FLOW DECREASED 2 0.0008
185 PROTHROMBIN TIME PROLONGED 5 0.0008
186 LACUNAR INFARCTION 2 0.0008
187 LACTIC ACIDOSIS 27 0.0008
188 MELAENA 18 0.0008
189 EXPIRED DRUG ADMINISTERED 4 0.0008
190 GASTROINTESTINAL SOUNDS ABNORMAL 4 0.0008
191 INTRAVENTRICULAR HAEMORRHAGE 2 0.0008
192 ENDODONTIC PROCEDURE 2 0.0008
193 HAEMORRHAGE URINARY TRACT 2 0.0008
194 INCREASED BRONCHIAL SECRETION 2 0.0008
195 PRESYNCOPE 19 0.0008
196 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 4 0.0008
197 MEDICATION RESIDUE 2 0.0008
198 HEPATOCELLULAR INJURY 11 0.0008
199 HERNIA REPAIR 2 0.0008
200 COMPARTMENT SYNDROME 2 0.0008
201 INCONTINENCE 8 0.0008
202 CEREBRAL ATROPHY 3 0.0008
203 CREATININE RENAL CLEARANCE DECREASED 3 0.0007
204 CANDIDIASIS 3 0.0007
205 ATRIOVENTRICULAR BLOCK COMPLETE 5 0.0007
206 LEFT VENTRICULAR DYSFUNCTION 5 0.0007
207 GINGIVITIS 4 0.0007
208 BRADYPNOEA 2 0.0007
209 MIGRAINE WITH AURA 2 0.0007
210 ACCIDENTAL POISONING 1 0.0007
211 HAEMODIALYSIS 6 0.0007
212 RIGHT VENTRICULAR FAILURE 5 0.0007
213 ENDOTRACHEAL INTUBATION 2 0.0007
214 PSYCHOMOTOR RETARDATION 2 0.0007
215 CARDIAC FAILURE CHRONIC 3 0.0007
216 HEPATIC PAIN 3 0.0007
217 HEART VALVE INCOMPETENCE 2 0.0007
218 TOXIC SKIN ERUPTION 7 0.0007
219 BLOOD URIC ACID INCREASED 4 0.0007
220 HAEMOTHORAX 2 0.0007
221 PURPURA 6 0.0007
222 THORACIC VERTEBRAL FRACTURE 2 0.0007
223 CARDIO-RESPIRATORY ARREST 28 0.0007
224 KETOACIDOSIS 5 0.0007
225 METABOLIC ENCEPHALOPATHY 2 0.0007
226 CRANIOCEREBRAL INJURY 2 0.0007
227 BLOOD PRESSURE SYSTOLIC DECREASED 3 0.0007
228 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0007
229 ISCHAEMIA 3 0.0007
230 PORTAL HYPERTENSION 2 0.0006
231 RENAL FAILURE ACUTE 27 0.0006
232 POISONING DELIBERATE 6 0.0006
233 BILE DUCT STONE 2 0.0006
234 PNEUMONIA VIRAL 2 0.0006
235 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
236 HYPOVOLAEMIC SHOCK 3 0.0006
237 FAECAL INCONTINENCE 3 0.0006
238 DRUG INTERACTION 99 0.0006
239 CUSHINGOID 2 0.0006
240 HYPOKINESIA 9 0.0006
241 HEART RATE IRREGULAR 14 0.0006
242 ACUTE LEUKAEMIA 1 0.0006
243 HYPOTENSION 124 0.0006
244 SHOCK HAEMORRHAGIC 5 0.0006
245 BACTERIAL SEPSIS 2 0.0006
246 HYPOVENTILATION 2 0.0006
247 LYMPHOCYTE COUNT INCREASED 2 0.0006
248 BREAST ENLARGEMENT 2 0.0006
249 SUSPECTED COVID-19 2 0.0006
250 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 2 0.0006
251 SKIN INJURY 2 0.0006
252 HEMIPLEGIA 5 0.0006
253 DERMATITIS EXFOLIATIVE 3 0.0006
254 CARDIAC ARREST 49 0.0006
255 CIRCULATORY COLLAPSE 10 0.0006
256 BRONCHOPNEUMONIA 2 0.0006
257 CEREBRAL ISCHAEMIA 3 0.0006
258 LARGE INTESTINE POLYP 4 0.0006
259 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
260 HYPERKALAEMIA 20 0.0006
261 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 5 0.0006
262 GLOSSITIS 2 0.0006
263 METABOLIC ACIDOSIS 18 0.0006
264 HAEMORRHAGIC DIATHESIS 2 0.0006
265 CARDIAC FAILURE 45 0.0006
266 HAEMOLYTIC ANAEMIA 5 0.0006
267 FACIAL BONES FRACTURE 2 0.0006
268 SCLERODERMA 2 0.0005
269 RETINOPATHY 2 0.0005
270 CHRONIC SINUSITIS 2 0.0005
271 PALPITATIONS 62 0.0005
272 NEUTROPHILIA 3 0.0005
273 NEUROLOGICAL SYMPTOM 3 0.0005
274 PARANASAL SINUS HYPERSECRETION 2 0.0005
275 OESOPHAGEAL ULCER 2 0.0005
276 OESOPHAGEAL DISORDER 2 0.0005
277 REHABILITATION THERAPY 2 0.0005
278 STRESS CARDIOMYOPATHY 3 0.0005
279 WOUND SECRETION 2 0.0005
280 OESOPHAGEAL PAIN 2 0.0005
281 IDIOPATHIC PULMONARY FIBROSIS 2 0.0005
282 SYNCOPE 50 0.0005
283 SKIN PAPILLOMA 2 0.0005
284 ARTERIOSPASM CORONARY 2 0.0005
285 GANGRENE 3 0.0005
286 HYPOGLYCAEMIA 24 0.0005
287 SUBARACHNOID HAEMORRHAGE 5 0.0005
288 SMALL INTESTINAL OBSTRUCTION 6 0.0005
289 ESCHERICHIA INFECTION 4 0.0005
290 PIGMENTATION DISORDER 3 0.0005
291 LEG AMPUTATION 2 0.0005
292 ACUTE CORONARY SYNDROME 4 0.0005
293 ACCIDENTAL EXPOSURE 2 0.0005
294 PERICARDIAL EFFUSION 11 0.0005
295 LIP OEDEMA 2 0.0005
296 SLEEP APNOEA SYNDROME 9 0.0005
297 ACUTE KIDNEY INJURY 72 0.0005
298 LUNG NEOPLASM 2 0.0005
299 RECTAL HAEMORRHAGE 20 0.0005
300 HEPATITIS ACUTE 3 0.0005
301 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
302 TONGUE DISCOLOURATION 2 0.0005
303 HAEMORRHAGIC ANAEMIA 2 0.0005
304 SOPOR 6 0.0005
305 BLOOD PRESSURE DECREASED 30 0.0005
306 RHINITIS ALLERGIC 2 0.0004
307 BASAL CELL CARCINOMA 7 0.0004
308 TRANSIENT ISCHAEMIC ATTACK 15 0.0004
309 WRONG PRODUCT ADMINISTERED 3 0.0004
310 HYPONATRAEMIA 25 0.0004
311 VASCULAR DEVICE INFECTION 2 0.0004
312 MYOCARDIAL ISCHAEMIA 5 0.0004
313 INTENTIONAL OVERDOSE 28 0.0004
314 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
315 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
316 HYPOPHAGIA 11 0.0004
317 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1 0.0004
318 DEPRESSED LEVEL OF CONSCIOUSNESS 17 0.0004
319 GASTRITIS EROSIVE 2 0.0004
320 HEART RATE DECREASED 15 0.0004
321 GASTRIC ULCER 8 0.0004
322 PRE-ECLAMPSIA 2 0.0004
323 CEREBRAL HAEMORRHAGE 15 0.0004
324 CHOLESTASIS 8 0.0004
325 ATELECTASIS 4 0.0004
326 LIVER FUNCTION TEST ABNORMAL 12 0.0004
327 HAEMORRHOIDAL HAEMORRHAGE 2 0.0004
328 LUNG DISORDER 20 0.0004
329 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
330 STAPHYLOCOCCAL SEPSIS 2 0.0004
331 EOSINOPHILIA 7 0.0004
332 EMPHYSEMA 4 0.0004
333 MEDICATION ERROR 22 0.0004
334 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
335 TROPONIN INCREASED 3 0.0004
336 DYSLIPIDAEMIA 2 0.0004
337 ISCHAEMIC STROKE 7 0.0004
338 PETIT MAL EPILEPSY 2 0.0004
339 PHLEBITIS 2 0.0004
340 HYPOKALAEMIA 18 0.0004
341 EAR DISCOMFORT 4 0.0004
342 THYROID DISORDER 6 0.0004
343 ANOREXIA 5 0.0004
344 UNRESPONSIVE TO STIMULI 10 0.0004
345 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 3 0.0004
346 EJECTION FRACTION DECREASED 6 0.0004
347 ACCIDENTAL OVERDOSE 14 0.0004
348 CATATONIA 2 0.0004
349 PULMONARY OEDEMA 17 0.0004
350 POLYARTHRITIS 2 0.0004
351 PHARYNGOLARYNGEAL PAIN 2 0.0004
352 BLOOD DISORDER 3 0.0004
353 COMPRESSION FRACTURE 2 0.0004
354 PRODUCT SIZE ISSUE 2 0.0004
355 BLOOD SODIUM DECREASED 7 0.0004
356 BLOOD CREATININE INCREASED 24 0.0004
357 POLYURIA 3 0.0004
358 GINGIVAL BLEEDING 5 0.0004
359 HYPERAESTHESIA 3 0.0004
360 PHOTOSENSITIVITY REACTION 6 0.0004
361 DEAFNESS UNILATERAL 2 0.0004
362 COMPLETED SUICIDE 30 0.0004
363 HEART RATE ABNORMAL 2 0.0004
364 ACUTE PULMONARY OEDEMA 2 0.0004
365 SKIN TOXICITY 2 0.0004
366 CHOLECYSTITIS ACUTE 2 0.0004
367 HEPATITIS 9 0.0004
368 CARDIAC VALVE DISEASE 2 0.0003
369 PSEUDOMONAS INFECTION 3 0.0003
370 HYPERTONIA 2 0.0003
371 SHOCK 8 0.0003
372 CORONARY ARTERY BYPASS 2 0.0003
373 EXERCISE TOLERANCE DECREASED 2 0.0003
374 MULTI-ORGAN FAILURE 6 0.0003
375 ORTHOSTATIC HYPOTENSION 6 0.0003
376 RALES 2 0.0003
377 TOXICITY TO VARIOUS AGENTS 58 0.0003
378 SKIN WARM 2 0.0003
379 PERIPHERAL SENSORY NEUROPATHY 2 0.0003
380 HYPOXIA 12 0.0003
381 LUNG INFILTRATION 3 0.0003
382 ENERGY INCREASED 2 0.0003
383 RESPIRATORY RATE INCREASED 3 0.0003
384 CATARACT OPERATION 2 0.0003
385 CARDIAC FAILURE CONGESTIVE 27 0.0003
386 MYOSITIS 3 0.0003
387 ENDOPHTHALMITIS 2 0.0003
388 TYPE 1 DIABETES MELLITUS 2 0.0003
389 HEPATITIS CHOLESTATIC 2 0.0003
390 LOCALISED INFECTION 8 0.0003
391 URINARY RETENTION 11 0.0003
392 ADRENAL INSUFFICIENCY 4 0.0003
393 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
394 MUSCULOSKELETAL CHEST PAIN 5 0.0003
395 AGRANULOCYTOSIS 6 0.0003
396 HAEMOPTYSIS 9 0.0003
397 ILEUS 4 0.0003
398 DELUSION 5 0.0003
399 LOSS OF CONSCIOUSNESS 41 0.0003
400 INFUSION SITE SWELLING 2 0.0003
401 PHOTOPSIA 2 0.0003
402 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
403 ABSCESS 5 0.0003
404 CHEST PAIN 58 0.0003
405 CARDIAC DISORDER 29 0.0003
406 INTERSTITIAL LUNG DISEASE 15 0.0003
407 HAEMATOMA 8 0.0003
408 BACK DISORDER 5 0.0003
409 PLATELET COUNT INCREASED 4 0.0003
410 TENDON DISORDER 2 0.0003
411 POLYP 2 0.0003
412 SOMNAMBULISM 2 0.0003
413 WALKING AID USER 2 0.0003
414 HAEMATOCRIT DECREASED 6 0.0003
415 HYPOTONIA 3 0.0003
416 CARDIAC FAILURE ACUTE 2 0.0003
417 MENINGITIS 2 0.0003
418 BLOOD UREA INCREASED 5 0.0003
419 HYPOTHERMIA 3 0.0003
420 SLUGGISHNESS 3 0.0003
421 PALLOR 8 0.0003
422 RENAL FAILURE 39 0.0003
423 ABNORMAL LOSS OF WEIGHT 2 0.0003
424 INFARCTION 2 0.0003
425 CORONARY ARTERY OCCLUSION 4 0.0003
426 ONYCHOCLASIS 2 0.0003
427 POOR VENOUS ACCESS 3 0.0003
428 RESPIRATORY DISTRESS 8 0.0003
429 ENCEPHALITIS 2 0.0003
430 HAIR GROWTH ABNORMAL 2 0.0003
431 PULMONARY HYPERTENSION 6 0.0003
432 COORDINATION ABNORMAL 4 0.0003
433 WEIGHT FLUCTUATION 3 0.0003
434 CEREBRAL INFARCTION 7 0.0003
435 TRANSFUSION 3 0.0003
436 RENAL IMPAIRMENT 24 0.0003
437 FULL BLOOD COUNT ABNORMAL 3 0.0003
438 DUODENAL ULCER 2 0.0003
439 CHEST DISCOMFORT 29 0.0003
440 HYPOTHYROIDISM 9 0.0003
441 PLEURAL EFFUSION 17 0.0003
442 IMPAIRED QUALITY OF LIFE 4 0.0003
443 DECREASED ACTIVITY 3 0.0003
444 PRURITUS GENERALISED 6 0.0003
445 MYELODYSPLASTIC SYNDROME 4 0.0003
446 TONGUE DISORDER 2 0.0003
447 HYPERTHYROIDISM 4 0.0003
448 FLUID RETENTION 14 0.0003
449 RASH PUSTULAR 2 0.0003
450 OESOPHAGITIS 3 0.0003
451 CHOLELITHIASIS 9 0.0003
452 APATHY 4 0.0003
453 GASTROENTERITIS 4 0.0003
454 MOUTH HAEMORRHAGE 2 0.0003
455 PSYCHIATRIC SYMPTOM 2 0.0003
456 HYPERTENSIVE CRISIS 3 0.0003
457 THINKING ABNORMAL 5 0.0003
458 BACTERIAL INFECTION 5 0.0003
459 HAEMORRHAGE INTRACRANIAL 4 0.0003
460 MUCOSAL INFLAMMATION 7 0.0003
461 PANCREATITIS ACUTE 6 0.0003
462 PAROSMIA 2 0.0003
463 FRACTURE 5 0.0003
464 SUICIDE ATTEMPT 16 0.0003
465 HAEMATURIA 9 0.0003
466 MICTURITION URGENCY 3 0.0003
467 INTERNAL HAEMORRHAGE 3 0.0003
468 HAEMODYNAMIC INSTABILITY 2 0.0003
469 ACIDOSIS 2 0.0003
470 NEOPLASM 3 0.0003
471 DISSOCIATION 2 0.0003
472 PROCEDURAL COMPLICATION 2 0.0003
473 RENAL FAILURE CHRONIC 2 0.0003
474 GLAUCOMA 5 0.0003
475 LYMPHOMA 4 0.0003
476 HERNIA 5 0.0003
477 PRESCRIBED OVERDOSE 5 0.0003
478 FALL 86 0.0003
479 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
480 HAEMORRHAGIC STROKE 2 0.0003
481 MUSCULAR WEAKNESS 29 0.0003
482 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
483 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
484 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
485 RENAL CYST 2 0.0003
486 HALLUCINATION, AUDITORY 4 0.0003
487 GINGIVAL PAIN 2 0.0003
488 MACULAR DEGENERATION 3 0.0003
489 HYPERLIPIDAEMIA 3 0.0003
490 HIP FRACTURE 8 0.0002
491 RHINITIS 2 0.0002
492 STENT PLACEMENT 2 0.0002
493 FIBROMYALGIA 6 0.0002
494 OEDEMA PERIPHERAL 30 0.0002
495 NO THERAPEUTIC RESPONSE 3 0.0002
496 BODY TEMPERATURE INCREASED 5 0.0002
497 CONVULSION 14 0.0002
498 FEELING HOT 15 0.0002
499 HYPERCALCAEMIA 3 0.0002
500 ABASIA 6 0.0002
501 STAPHYLOCOCCAL INFECTION 8 0.0002
502 SPINAL COMPRESSION FRACTURE 2 0.0002
503 ANAEMIA 46 0.0002
504 EMBOLISM 2 0.0002
505 MYOCARDIAL INFARCTION 42 0.0002
506 OEDEMA 13 0.0002
507 POISONING 3 0.0002
508 URINARY INCONTINENCE 7 0.0002
509 CONFUSIONAL STATE 38 0.0002
510 ANAPHYLACTIC SHOCK 6 0.0002
511 ABNORMAL SENSATION IN EYE 1 0.0002
512 PANCYTOPENIA 13 0.0002
513 POOR QUALITY SLEEP 5 0.0002
514 HEART RATE INCREASED 23 0.0002
515 CARDIAC MURMUR 2 0.0002
516 DIPLOPIA 6 0.0002
517 PYELONEPHRITIS 2 0.0002
518 JOINT STIFFNESS 6 0.0002
519 GASTRITIS 6 0.0002
520 PULMONARY CONGESTION 3 0.0002
521 GASTROINTESTINAL HAEMORRHAGE 19 0.0002
522 EPISTAXIS 17 0.0002
523 ABDOMINAL ABSCESS 1 0.0002
524 FEMUR FRACTURE 7 0.0002
525 PRODUCT SUBSTITUTION ISSUE 13 0.0002
526 TOOTH DISORDER 5 0.0002
527 DIZZINESS 112 0.0002
528 FACIAL PAIN 2 0.0002
529 JOINT RANGE OF MOTION DECREASED 3 0.0002
530 GASTROENTERITIS VIRAL 4 0.0002
531 TACHYPNOEA 3 0.0002
532 LUPUS-LIKE SYNDROME 2 0.0002
533 MOOD ALTERED 6 0.0002
534 GAIT DISTURBANCE 42 0.0002
535 CATARACT 13 0.0002
536 NEPHROLITHIASIS 10 0.0002
537 SKIN DISCOLOURATION 10 0.0002
538 RETINAL DETACHMENT 2 0.0002
539 TREATMENT FAILURE 18 0.0002
540 OVARIAN CANCER 2 0.0002
541 IRON DEFICIENCY ANAEMIA 2 0.0002
542 BLOOD PRESSURE INCREASED 33 0.0002
543 RHABDOMYOLYSIS 9 0.0002
544 FEELING COLD 6 0.0002
545 DIARRHOEA HAEMORRHAGIC 2 0.0002
546 DYSPNOEA 121 0.0002
547 INFLAMMATION 11 0.0002
548 LACERATION 2 0.0002
549 ARTERIOSCLEROSIS 2 0.0002
550 SQUAMOUS CELL CARCINOMA 2 0.0002
551 DYSPNOEA EXERTIONAL 8 0.0002
552 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
553 FLATULENCE 12 0.0002
554 SINUS TACHYCARDIA 3 0.0002
555 ECZEMA 11 0.0002
556 PRODUCT PRESCRIBING ERROR 5 0.0002
557 PARALYSIS 3 0.0002
558 ANGINA PECTORIS 6 0.0002
559 BLOOD PRESSURE FLUCTUATION 5 0.0002
560 GENERAL PHYSICAL HEALTH DETERIORATION 24 0.0002
561 CONDITION AGGRAVATED 63 0.0002
562 HYPERCHOLESTEROLAEMIA 2 0.0002
563 PULMONARY ARTERIAL HYPERTENSION 3 0.0002
564 FLUID OVERLOAD 3 0.0002
565 DISTURBANCE IN ATTENTION 11 0.0002
566 VITREOUS FLOATERS 2 0.0002
567 THERAPY CHANGE 2 0.0002
568 CARDIOMYOPATHY 3 0.0002
569 BLADDER DISORDER 2 0.0002
570 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
571 AGEUSIA 5 0.0002
572 PRODUCT PHYSICAL ISSUE 4 0.0002
573 OSTEOPENIA 3 0.0002
574 EYELID PTOSIS 2 0.0002
575 FLUSHING 20 0.0002
576 DRUG DISPENSING ERROR 3 0.0002
577 NEUTROPHIL COUNT INCREASED 2 0.0002
578 EUPHORIC MOOD 2 0.0002
579 DEHYDRATION 26 0.0002
580 INITIAL INSOMNIA 2 0.0002
581 SKIN ULCER 5 0.0002
582 LUNG INFECTION 3 0.0002
583 EXPOSURE DURING PREGNANCY 12 0.0002
584 PHARMACEUTICAL PRODUCT COMPLAINT 5 0.0002
585 PETECHIAE 2 0.0002
586 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
587 HEAD INJURY 6 0.0002
588 HALLUCINATION, VISUAL 4 0.0002
589 PNEUMOTHORAX 3 0.0002
590 SUDDEN DEATH 2 0.0002
591 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
592 OBESITY 3 0.0002
593 EATING DISORDER 4 0.0002
594 CONTUSION 18 0.0002
595 DYSARTHRIA 7 0.0002
596 JAUNDICE 5 0.0002
597 SKIN CANCER 4 0.0002
598 BLOOD POTASSIUM INCREASED 3 0.0002
599 COLITIS 7 0.0002
600 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
601 FAECES DISCOLOURED 4 0.0002
602 BACK INJURY 2 0.0002
603 NEUTROPENIA 25 0.0002
604 DIABETES MELLITUS 14 0.0002
605 WOUND INFECTION 2 0.0002
606 ASPIRATION 2 0.0002
607 BLOOD GLUCOSE FLUCTUATION 2 0.0002
608 GASTROINTESTINAL PAIN 2 0.0002
609 VISUAL ACUITY REDUCED 6 0.0002
610 FOOT DEFORMITY 2 0.0002
611 MENTAL STATUS CHANGES 5 0.0002
612 TRANSAMINASES INCREASED 4 0.0002
613 SKIN DISORDER 6 0.0002
614 RASH MACULO-PAPULAR 4 0.0002
615 THROMBOCYTOPENIA 20 0.0002
616 MALNUTRITION 2 0.0002
617 PERICARDITIS 3 0.0002
618 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
619 INTESTINAL PERFORATION 2 0.0002
620 FISTULA 2 0.0002
621 BLOOD CALCIUM DECREASED 2 0.0002
622 IMPAIRED DRIVING ABILITY 2 0.0002
623 ASTHENIA 66 0.0002
624 SCAB 2 0.0002
625 LOCAL SWELLING 3 0.0002
626 POST PROCEDURAL HAEMORRHAGE 2 0.0002
627 VASCULITIS 2 0.0002
628 SPLENOMEGALY 2 0.0002
629 PANCREATITIS 9 0.0002
630 ASCITES 5 0.0002
631 URINARY TRACT INFECTION 29 0.0002
632 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
633 HEAD DISCOMFORT 3 0.0002
634 TACHYCARDIA 15 0.0002
635 COMA 8 0.0002
636 RESPIRATORY DISORDER 5 0.0002
637 BLOOD POTASSIUM DECREASED 5 0.0002
638 TOOTHACHE 3 0.0002
639 OSTEOMYELITIS 3 0.0002
640 HAEMOGLOBIN DECREASED 17 0.0002
641 CORONARY ARTERY DISEASE 5 0.0002
642 MENTAL IMPAIRMENT 4 0.0002
643 C-REACTIVE PROTEIN INCREASED 6 0.0002
644 END STAGE RENAL DISEASE 3 0.0002
645 VERTIGO 10 0.0002
646 EPILEPSY 5 0.0002
647 DRUG ADMINISTRATION ERROR 5 0.0002
648 ANAPHYLACTIC REACTION 9 0.0002
649 ENCEPHALOPATHY 4 0.0002
650 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
651 BLOOD GLUCOSE ABNORMAL 3 0.0002
652 OVERDOSE 35 0.0002
653 TENDON RUPTURE 2 0.0002
654 LIMB DISCOMFORT 5 0.0002
655 HEPATIC ENZYME INCREASED 11 0.0002
656 HEPATIC STEATOSIS 3 0.0002
657 NECK PAIN 9 0.0002
658 PNEUMONIA ASPIRATION 4 0.0002
659 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
660 PHOTOPHOBIA 3 0.0002
661 BACK PAIN 37 0.0002
662 HALLUCINATION 12 0.0002
663 HYPOCALCAEMIA 3 0.0002
664 BLOOD URINE PRESENT 3 0.0002
665 PROTEINURIA 3 0.0002
666 LETHARGY 9 0.0002
667 CONSTIPATION 34 0.0002
668 MYDRIASIS 2 0.0002
669 ADVERSE DRUG REACTION 14 0.0002
670 ROTATOR CUFF SYNDROME 2 0.0002
671 RHINORRHOEA 10 0.0002
672 EAR PAIN 3 0.0002
673 DYSPHONIA 9 0.0002
674 HAEMORRHOIDS 3 0.0002
675 RESPIRATORY TRACT INFECTION 4 0.0002
676 SKIN FISSURES 3 0.0002
677 CEREBROVASCULAR ACCIDENT 26 0.0002
678 NODULE 2 0.0002
679 HAEMORRHAGE 16 0.0002
680 DEAFNESS 4 0.0002
681 TINNITUS 7 0.0002
682 IMPAIRED HEALING 5 0.0002
683 BEDRIDDEN 2 0.0002
684 IMMUNE SYSTEM DISORDER 2 0.0002
685 COUGH 42 0.0001
686 CYTOKINE RELEASE SYNDROME 3 0.0001
687 MALIGNANT MELANOMA 2 0.0001
688 QUALITY OF LIFE DECREASED 2 0.0001
689 FULL BLOOD COUNT DECREASED 3 0.0001
690 TYPE 2 DIABETES MELLITUS 5 0.0001
691 PRODUCT TASTE ABNORMAL 2 0.0001
692 FOETAL EXPOSURE DURING PREGNANCY 12 0.0001
693 DYSPHAGIA 14 0.0001
694 HYPERHIDROSIS 19 0.0001
695 HYPERTENSION 31 0.0001
696 GASTRIC DISORDER 5 0.0001
697 PERIPHERAL COLDNESS 2 0.0001
698 INFLUENZA 16 0.0001
699 ROAD TRAFFIC ACCIDENT 6 0.0001
700 WEIGHT DECREASED 40 0.0001
701 MASS 2 0.0001
702 OXYGEN SATURATION DECREASED 8 0.0001
703 BLOOD TEST ABNORMAL 2 0.0001
704 DYSPEPSIA 14 0.0001
705 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
706 BLINDNESS UNILATERAL 2 0.0001
707 OSTEOARTHRITIS 6 0.0001
708 LYMPHOPENIA 2 0.0001
709 SEASONAL ALLERGY 2 0.0001
710 PLATELET COUNT DECREASED 15 0.0001
711 BRONCHOSPASM 2 0.0001
712 HYPERSOMNIA 4 0.0001
713 MALAISE 61 0.0001
714 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
715 SWELLING 13 0.0001
716 PANCREATIC CARCINOMA 4 0.0001
717 SEPTIC SHOCK 6 0.0001
718 INJECTION SITE HAEMATOMA 2 0.0001
719 PRODUCT DISPENSING ERROR 3 0.0001
720 RESPIRATORY FAILURE 10 0.0001
721 RESTLESSNESS 5 0.0001
722 BONE PAIN 8 0.0001
723 ACUTE MYOCARDIAL INFARCTION 4 0.0001
724 MYALGIA 23 0.0001
725 COLITIS ULCERATIVE 6 0.0001
726 COLON CANCER 2 0.0001
727 ORAL PAIN 3 0.0001
728 HEPATIC FUNCTION ABNORMAL 5 0.0001
729 RASH PAPULAR 3 0.0001
730 SPEECH DISORDER 7 0.0001
731 CHROMATURIA 3 0.0001
732 HYPOAESTHESIA ORAL 2 0.0001
733 PAIN IN EXTREMITY 39 0.0001
734 VISION BLURRED 18 0.0001
735 PERIPHERAL SWELLING 20 0.0001
736 VISUAL IMPAIRMENT 16 0.0001
737 COGNITIVE DISORDER 6 0.0001
738 TREATMENT NONCOMPLIANCE 7 0.0001
739 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
740 BALANCE DISORDER 11 0.0001
741 CYANOSIS 2 0.0001
742 RESPIRATORY TRACT CONGESTION 2 0.0001
743 ULCER 2 0.0001
744 PREMATURE DELIVERY 2 0.0001
745 SEPSIS 14 0.0001
746 DIABETIC KETOACIDOSIS 3 0.0001
747 SENSORY DISTURBANCE 2 0.0001
748 MOVEMENT DISORDER 4 0.0001
749 GASTROOESOPHAGEAL REFLUX DISEASE 10 0.0001
750 SOMNOLENCE 25 0.0001
751 MEMORY IMPAIRMENT 17 0.0001
752 MUSCLE TIGHTNESS 2 0.0001
753 GASTROINTESTINAL DISORDER 11 0.0001
754 LIVER INJURY 3 0.0001
755 FATIGUE 95 0.0001
756 METASTASES TO BONE 2 0.0001
757 OSTEOPOROSIS 5 0.0001
758 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
759 DRUG LEVEL INCREASED 2 0.0001
760 INFUSION RELATED REACTION 8 0.0001
761 FEBRILE NEUTROPENIA 8 0.0001
762 VIRAL INFECTION 4 0.0001
763 LEUKOPENIA 6 0.0001
764 HOT FLUSH 9 0.0001
765 NAUSEA 94 0.0001
766 FACE OEDEMA 2 0.0001
767 CARDIOVASCULAR DISORDER 3 0.0001
768 HEMIPARESIS 2 0.0001
769 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
770 PNEUMONIA 38 0.0001
771 SINUSITIS 12 0.0001
772 ERYTHEMA 24 0.0001
773 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
774 RASH GENERALISED 3 0.0001
775 PULMONARY EMBOLISM 11 0.0001
776 THERAPEUTIC RESPONSE DECREASED 7 0.0001
777 ILL-DEFINED DISORDER 7 0.0001
778 PRURITUS 44 0.0001
779 INCORRECT DOSE ADMINISTERED 26 0.0001
780 DRUG INTOLERANCE 11 0.0001
781 ABDOMINAL DISCOMFORT 19 0.0001
782 LYMPHOCYTE COUNT DECREASED 2 0.0001
783 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
784 GALLBLADDER DISORDER 2 0.0001
785 THIRST 2 0.0001
786 FEAR 3 0.0001
787 GOUT 2 0.0001
788 FREQUENT BOWEL MOVEMENTS 3 0.0001
789 BLOOD BILIRUBIN INCREASED 3 0.0001
790 WHITE BLOOD CELL COUNT DECREASED 12 0.0001
791 PNEUMONITIS 3 0.0001
792 DRUG EFFECT INCOMPLETE 4 0.0001
793 RESTLESS LEGS SYNDROME 2 0.0001
794 DRUG INEFFECTIVE 144 0.0001
795 INSOMNIA 29 0.0001
796 HAEMATOCHEZIA 6 0.0001
797 DIVERTICULITIS 3 0.0001
798 BRONCHITIS 8 0.0001
799 OROPHARYNGEAL PAIN 10 0.0001
800 DEEP VEIN THROMBOSIS 7 0.0001
801 DYSGEUSIA 8 0.0001
802 ABDOMINAL PAIN 25 0.0001
803 WOUND 3 0.0001
804 MIDDLE INSOMNIA 2 0.0001
805 SKIN EXFOLIATION 9 0.0001
806 HEPATIC CIRRHOSIS 2 0.0001
807 VOMITING 50 0.0001
808 BLOOD GLUCOSE INCREASED 20 0.0001
809 INTESTINAL OBSTRUCTION 4 0.0001
810 PAIN IN JAW 3 0.0001
811 MUSCULOSKELETAL DISORDER 2 0.0001
812 RED BLOOD CELL COUNT DECREASED 3 0.0001
813 PRODUCTIVE COUGH 5 0.0001
814 BLOOD GLUCOSE DECREASED 5 0.0001
815 SEROTONIN SYNDROME 2 0.0001
816 ACUTE RESPIRATORY FAILURE 2 0.0001
817 ERUCTATION 2 0.0001
818 DECREASED APPETITE 24 0.0001
819 MUSCULOSKELETAL STIFFNESS 9 0.0001
820 ORAL HERPES 2 0.0001
821 CHILLS 12 0.0001
822 KIDNEY INFECTION 2 0.0001
823 WHEEZING 6 0.0001
824 ARTHRALGIA 42 0.0001
825 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
826 SINUS DISORDER 2 0.0001
827 ABNORMAL BEHAVIOUR 4 0.0001
828 DISORIENTATION 4 0.0001
829 PRESCRIBED UNDERDOSE 2 0.0001
830 DRY EYE 5 0.0001
831 FEELING ABNORMAL 24 0.0001
832 SPINAL FRACTURE 2 0.0001
833 PREMATURE BABY 3 0.0001
834 THROMBOSIS 8 0.0001
835 APHASIA 3 0.0001
836 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
837 DRY MOUTH 8 0.0001
838 PRODUCT PREPARATION ERROR 2 0.0001
839 INFLUENZA LIKE ILLNESS 8 0.0001
840 ALOPECIA 19 0.0001
841 POLLAKIURIA 4 0.0001
842 DRUG-INDUCED LIVER INJURY 3 0.0001
843 MUSCULOSKELETAL PAIN 5 0.0001
844 PARAESTHESIA 15 0.0001
845 NEUROPATHY PERIPHERAL 9 0.0001
846 DIARRHOEA 61 0.0001
847 RETCHING 2 0.0001
848 HYPOACUSIS 4 0.0001
849 PRODUCT USE IN UNAPPROVED INDICATION 23 0.0001
850 ABDOMINAL PAIN UPPER 19 0.0001
851 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
852 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
853 OSTEONECROSIS 3 0.0001
854 JOINT SWELLING 11 0.0001
855 ANGIOEDEMA 4 0.0001
856 LIP SWELLING 3 0.0001
857 FUNGAL INFECTION 3 0.0001
858 WEIGHT INCREASED 20 0.0001
859 EYE PRURITUS 3 0.0001
860 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
861 THROAT IRRITATION 4 0.0001
862 BLISTER 5 0.0001
863 THERAPY NON-RESPONDER 4 0.0001
864 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
865 PRODUCT AVAILABILITY ISSUE 2 0.0001
866 HERPES ZOSTER 5 0.0001
867 MUSCLE TWITCHING 2 0.0001
868 NIGHTMARE 3 0.0001
869 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
870 RASH MACULAR 3 0.0001
871 DEVICE MALFUNCTION 6 0.0001
872 NASAL CONGESTION 5 0.0001
873 RASH 37 0.0001
874 DISEASE PROGRESSION 10 0.0001
875 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
876 INCORRECT ROUTE OF DRUG ADMINISTRATION 3 0.0001
877 RASH ERYTHEMATOUS 4 0.0001
878 DEPRESSION 19 0.0001
879 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
880 DYSURIA 3 0.0001
881 INJECTION SITE MASS 3 0.0001
882 OFF LABEL USE 71 0.0001
883 PYREXIA 28 0.0001
884 HEADACHE 50 0.0001
885 CELLULITIS 4 0.0001
886 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
887 ABDOMINAL PAIN LOWER 2 0.0001
888 CHRONIC KIDNEY DISEASE 6 0.0001
889 HAEMATEMESIS 2 0.0001
890 TREMOR 13 0.0001
891 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
892 THERAPY CESSATION 4 0.0001
893 ANXIETY 22 0.0001
894 ARTHRITIS 6 0.0001
895 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
896 EAR INFECTION 2 0.0001
897 THROAT TIGHTNESS 2 0.0001
898 PSORIATIC ARTHROPATHY 3 0.0001
899 DYSKINESIA 3 0.0001
900 RASH PRURITIC 4 0.0001
901 LIMB INJURY 2 0.0001
902 BLINDNESS 3 0.0001
903 SKIN LESION 2 0.0001
904 INJECTION SITE ERYTHEMA 9 0.0001
905 ABNORMAL DREAMS 2 0.0001
906 HOSPITALISATION 11 0.0001
907 BURNING SENSATION 5 0.0001
908 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
909 SLEEP DISORDER 5 0.0001
910 ASTHMA 8 0.0001
911 NASOPHARYNGITIS 13 0.0001
912 INTENTIONAL DOSE OMISSION 2 0.0001
913 EYE IRRITATION 4 0.0001
914 DYSSTASIA 2 0.0001
915 SURGERY 4 0.0001
916 AGITATION 5 0.0001
917 PRODUCT DOSE OMISSION ISSUE 20 0.0001
918 LABORATORY TEST ABNORMAL 2 0.0001
919 RENAL INJURY 2 0.0001
920 MATERNAL EXPOSURE DURING PREGNANCY 6 0.0001
921 HYPOAESTHESIA 10 0.0001
922 HEPATIC FAILURE 2 0.0001
923 LACRIMATION INCREASED 2 0.0001
924 ACNE 5 0.0001
925 DISCOMFORT 4 0.0001
926 SUICIDAL IDEATION 6 0.0001
927 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
928 GYNAECOMASTIA 2 0.0001
929 RENAL DISORDER 3 0.0001
930 BLOOD CHOLESTEROL INCREASED 3 0.0001
931 SWOLLEN TONGUE 2 0.0001
932 PRODUCT USE ISSUE 12 0.0001
933 MIGRAINE 6 0.0001
934 PAIN 38 0.0001
935 DEATH 53 0.0001
936 SWELLING FACE 4 0.0001
937 EYE DISORDER 2 0.0001
938 EXPIRED PRODUCT ADMINISTERED 2 0.0001
939 DRUG ABUSE 5 0.0001
940 MUSCLE SPASMS 11 0.0001
941 AGGRESSION 3 0.0001
942 HYPERSENSITIVITY 11 0.0001
943 NEOPLASM PROGRESSION 2 0.0001
944 NERVOUSNESS 3 0.0001
945 LYMPHADENOPATHY 2 0.0001
946 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
947 SKIN BURNING SENSATION 4 0.0001
948 DRUG EFFECT DECREASED 3 0.0001
949 MOBILITY DECREASED 4 0.0001
950 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
951 ADVERSE EVENT 5 0.0001
952 ARTHROPATHY 3 0.0001
953 URTICARIA 9 0.0001
954 EYE PAIN 3 0.0001
955 SEIZURE 6 0.0001
956 INJECTION SITE BRUISING 4 0.0001
957 EXTRA DOSE ADMINISTERED 2 0.0000
958 NEUTROPHIL COUNT DECREASED 2 0.0000
959 INJECTION SITE PAIN 15 0.0000
960 LUNG NEOPLASM MALIGNANT 2 0.0000
961 ILLNESS 5 0.0000
962 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
963 ABDOMINAL DISTENSION 5 0.0000
964 AMNESIA 3 0.0000
965 VAGINAL HAEMORRHAGE 2 0.0000
966 DEVICE DISLOCATION 2 0.0000
967 PRODUCT DOSE OMISSION 3 0.0000
968 PSORIASIS 6 0.0000
969 LIVER DISORDER 2 0.0000
970 DRY SKIN 6 0.0000
971 INJECTION SITE PRURITUS 3 0.0000
972 PRODUCT QUALITY ISSUE 6 0.0000
973 INJECTION SITE REACTION 3 0.0000
974 BREAST CANCER 4 0.0000
975 INJURY 3 0.0000
976 OCULAR HYPERAEMIA 2 0.0000
977 DISEASE RECURRENCE 2 0.0000
978 INFECTION 6 0.0000
979 COVID-19 7 0.0000
980 UNEVALUABLE EVENT 3 0.0000
981 DEPRESSED MOOD 2 0.0000
982 INJECTION SITE HAEMORRHAGE 3 0.0000
983 RHEUMATOID ARTHRITIS 4 0.0000
984 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
985 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
986 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
987 STOMATITIS 2 0.0000
988 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
989 THERAPY INTERRUPTED 2 0.0000
990 PROSTATE CANCER 2 0.0000
991 DRUG DOSE OMISSION 4 0.0000
992 NO ADVERSE EVENT 2 0.0000